APA (7th ed.) Citation

Han, F., Guo, H., Zhang, H., & Zheng, Y. (2025). hs-CRP/HDL-C can predict the risk of all cause mortality in cardiovascular-kidney-metabolic syndrome stage 1-4 patients. Frontiers in Endocrinology, 16, . https://doi.org/10.3389/fendo.2025.1552219

Chicago Style (17th ed.) Citation

Han, Fengjiao, Haiyang Guo, Hao Zhang, and Yang Zheng. "Hs-CRP/HDL-C Can Predict the Risk of All Cause Mortality in Cardiovascular-kidney-metabolic Syndrome Stage 1-4 Patients." Frontiers in Endocrinology 16 (2025). https://doi.org/10.3389/fendo.2025.1552219.

MLA (8th ed.) Citation

Han, Fengjiao, et al. "Hs-CRP/HDL-C Can Predict the Risk of All Cause Mortality in Cardiovascular-kidney-metabolic Syndrome Stage 1-4 Patients." Frontiers in Endocrinology, vol. 16, 2025, https://doi.org/10.3389/fendo.2025.1552219.

Warning: These citations may not always be 100% accurate.
Visit our Citation Styles guide for help on properly citing sources.